|Bid||13.03 x 800|
|Ask||13.46 x 1400|
|Day's range||12.97 - 14.06|
|52-week range||11.15 - 31.97|
|Beta (5Y monthly)||1.01|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||09 Nov 2010|
|1y target est||30.47|
Potential Bausch Health Companies Inc. (NYSE:BHC) shareholders may wish to note that insider Richard DeSchutter...
Bausch Health Companies Inc. (NYSE:BHC) shares fell 4.5% to US$26.50 in the week since its latest full-year results...
Bausch (BHC) delivered earnings and revenue surprises of 0.00% and -0.02%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Bausch Health (BHC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Bausch (BHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But in contrast you can...
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Bausch Health Companies is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.